Send to

Choose Destination
Curr Opin Immunol. 1997 Aug;9(4):517-24.

Recombinant viruses as vaccines and immunological tools.

Author information

Department of Immunology, Max Planck Institute for Infection Biology, Monbijoustrasse 2, D-10117, Berlin, Germany.


Recombinant viruses have been investigated as candidate vaccines, and have also been used extensively as immunological tools. Recent advances in this area include the following: the construction and testing of a recombinant simian immunodeficiency virus encoding human interferon-gamma; the development of new vectors such as recombinant poliovirus; and the generation of polyepitope vaccines. Basic immunological research has benefited from the use of recombinant viruses to further understand the role of molecules such as CD40 ligand, nitric oxide and interleukin-4.

Comment in

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center